搜索优化
English
全部
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
生物通
27 天
Vertex 非阿片镇痛药获批,开启 NaV1.8 靶点疼痛治疗新时代
最终,Vertex 公司的坚持得到了回报。最近获批的 Journavx 对 NaV1.1 - 1.7 和 NaV1.9 的亲和力达到亚纳摩尔级别,且选择性超过 31000 倍。 在该药物的 3 期临床试验中,2000 多名接受拇囊炎切除手术或腹部整容手术的患者,分别每 12 小时服用一次 Journavx、每 6 小时服用 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Will speak on Tuesday
Oklahoma wildfires
Israeli attack in Gaza
Iran denies US claims
To review F-35 jets purchase
Former NY Rep. Lowey dies
Staff placed on leave
Syed formally resentenced
Names new military chief
Former NFL receiver dies
US vows to hit Houthis
Severe weather outbreak
Quake strikes Malibu area
NCAA '25 brackets revealed
Deported despite valid visa?
Survives 95 days at sea
RU, UKR launch attacks
US deports Venezuelans
North Macedonia deadly fire
Electrical fire halts show
US expels SA ambassador
Crew-10 arrives at ISS
SuperSonics icon dies
US mulls travel ban
Man set on fire in NYC
Withdraws nomination
Man wins $50M over burns
Chiefs sign Tillery
Cuba suffers power outage
Jets sign Derrick Nnadi
Kellogg's envoy role reduced
反馈